Welcome to our dedicated page for ORMAT TECHNOLOGIES SEC filings (Ticker: ORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ORMAT TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ORMAT TECHNOLOGIES's regulatory disclosures and financial reporting.
Ormat Technologies, Inc. (ORA) has filed a Form 144 notice with the SEC indicating an insider’s intent to sell 8,548 shares of common stock.
The proposed sale, to be executed through Morgan Stanley Smith Barney LLC on the NYSE around 24 June 2025, carries an aggregate market value of $737,760.78. Based on the company’s 60,662,626 shares outstanding, the transaction represents roughly 0.014 % of total shares, implying minimal dilution.
The shares stem from equity-based compensation awards granted between May 2022 and March 2025, including restricted stock and performance shares. The filing shows no sales by the same insider during the past three months, and the seller certifies that no undisclosed material adverse information is known.
The identity and role of the seller are not provided in the filing, limiting insight into potential signaling effects. Nevertheless, Form 144 filings can sometimes influence sentiment because they reveal insider monetization plans, even when the amount is immaterial in percentage terms.
This Form 4/A is an amendment to a previously filed Form 4 for David Granot, a Director of Ormat Technologies (NYSE: ORA), correcting an administrative error in the reported beneficial ownership following a stock transaction.
Key details of the filing:
- Transaction Date: June 18, 2025
- Transaction: Sale of 1,072 shares of common stock at $85 per share
- Post-transaction Holdings: 1,641 shares (corrected from previously reported 2,479 shares)
- Filing Type: Direct ownership
The amendment was filed on June 28, 2025, correcting the Form 4 originally filed on June 20, 2025. The correction specifically addresses Box 5 (Amount of Securities Beneficially Owned) which was incorrectly reported due to an administrative error. The filing was signed by Jessica Woelfel as attorney-in-fact.
Jessica Woelfel, General Counsel, Chief Compliance Officer, and Corporate Secretary of Ormat Technologies (NYSE: ORA), reported insider sales transactions executed on June 18, 2025, pursuant to a pre-established 10b5-1 trading plan from December 2024.
The transactions involved two separate sales of common stock:
- Sale of 251 shares at $82 per share
- Sale of 313 shares at $85 per share
Following these transactions, Woelfel retains direct beneficial ownership of 5,926 shares of Ormat Technologies common stock. The sales were executed according to a predetermined trading plan, which helps demonstrate compliance with insider trading regulations and provides an affirmative defense against potential allegations of trading on material non-public information.
Ormat Technologies, Inc. (ORA) – Form 4 insider transaction
Director David Granot reported the sale of 1,072 shares of Ormat Technologies common stock on 18 June 2025 at a price of $85.00 per share. Following the disposition, Granot directly owns 2,479 shares of ORA. No derivative securities were reported, and there were no purchases disclosed. The filing was signed on 20 June 2025 by attorney-in-fact Jessica Woelfel.
The transaction represents a modest reduction of the director’s direct holdings and amounts to a cash value of roughly $91 thousand. Given Ormat’s total shares outstanding, the trade is immaterial to the company’s capital structure. Nevertheless, investors often monitor insider sales for potential sentiment signals.
Ormat Technologies, Inc. (ORA) Form 144 filing discloses a planned sale of 1,072 common shares through Morgan Stanley Smith Barney on 18 June 2025. The shares have an aggregate market value of $91,120. This represents roughly 0.0018 % of Ormat’s 60.66 million shares outstanding, indicating a very small transaction relative to overall float.
The seller, David Granot (relationship to issuer not specified in the filing), previously acquired the shares as restricted stock on 2 November 2023 (311 shares) and 9 May 2024 (761 shares). The filing also lists sales by the same individual during the last three months: 838 shares sold on 14 May 2025 for $61,176 and 112 shares sold on 13 May 2025 for $8,270.
No financial performance data or operational updates are included; the document is limited to disclosure of the proposed insider transaction under SEC Rule 144. Given the modest size of the sale, it is unlikely to have a material impact on ORA’s share price, but investors may nevertheless track insider selling trends for sentiment signals.
Ormat Technologies, Inc. (ORA) filed a Form 144 indicating a proposed insider sale of common stock.
The filing covers 564 shares valued at $47,187 (based on the market price as of the filing) to be executed through Morgan Stanley Smith Barney LLC on or after 18 June 2025 on the NYSE. The shares represent approximately 0.0009 % of the company’s 60,662,626 shares outstanding, signalling an immaterial percentage of equity.
The seller acquired the shares on 18 June 2025 via Stock Appreciation Rights and will pay cash upon exercise. The same individual—identified in the past-3-month sales table as Jessica Woelfel—has already sold 170 shares on 25 March 2025, generating gross proceeds of $12,165.20.
No earnings data, strategic transactions or material corporate developments are disclosed; the form is strictly a notice of intent to sell securities. Given the negligible size relative to the public float, the transaction is unlikely to affect liquidity, control, or valuation for current investors.